Identification of inhibitors against interaction between pro-inflammatory sPLA2-IIA protein and integrin αvβ3

Long Ye, Tiffany Dickerson, Handeep Kaur, Yoko K. Takada, Masaaki Fujita, Ruiwu Liu, John M. Knapp, Kit Lam, Neil E. Schore, Mark J. Kurth, Yoshikazu Takada

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Increased concentrations of secreted phospholipase A2 type IIA (sPLA2-IIA), have been found in the synovial fluid of patients with rheumatoid arthritis. It has been shown that sPLA2-IIA specifically binds to integrin αvβ3, and initiates a signaling pathway that leads to cell proliferation and inflammation. Therefore, the interaction between integrin and sPLA2-IIA could be a potential therapeutic target for the treatment of proliferation or inflammation-related diseases. Two one-bead-one-compound peptide libraries were constructed and screened, and seven target hits were identified. Herein we report the identification, synthesis, and biological testing of two pyrazolylthiazole-tethered peptide hits and their analogs. Biological assays showed that these compounds were able to suppress the sPLA2-IIA-integrin interaction and sPLA2-IIA-induced migration of monocytic cells and that the blockade of the sPLA2-IIA-integrin binding was specific to sPLA2-IIA and not to the integrin.

Original languageEnglish (US)
Pages (from-to)340-345
Number of pages6
JournalBioorganic and Medicinal Chemistry Letters
Volume23
Issue number1
DOIs
StatePublished - Jan 1 2013

Fingerprint

Secretory Phospholipase A2
Integrins
Proteins
Inflammation
Peptide Library
Synovial Fluid
Cell proliferation
Biological Assay
Cell Movement
Assays
Rheumatoid Arthritis
Cells
Cell Proliferation
Peptides
Fluids
Testing
Therapeutics

Keywords

  • Inflammation
  • Inhibition of protein-protein interaction
  • Integrin
  • sPLA2-IIA

ASJC Scopus subject areas

  • Pharmaceutical Science
  • Drug Discovery
  • Organic Chemistry
  • Molecular Medicine
  • Molecular Biology
  • Clinical Biochemistry
  • Biochemistry

Cite this

Identification of inhibitors against interaction between pro-inflammatory sPLA2-IIA protein and integrin αvβ3. / Ye, Long; Dickerson, Tiffany; Kaur, Handeep; Takada, Yoko K.; Fujita, Masaaki; Liu, Ruiwu; Knapp, John M.; Lam, Kit; Schore, Neil E.; Kurth, Mark J.; Takada, Yoshikazu.

In: Bioorganic and Medicinal Chemistry Letters, Vol. 23, No. 1, 01.01.2013, p. 340-345.

Research output: Contribution to journalArticle

Ye, Long ; Dickerson, Tiffany ; Kaur, Handeep ; Takada, Yoko K. ; Fujita, Masaaki ; Liu, Ruiwu ; Knapp, John M. ; Lam, Kit ; Schore, Neil E. ; Kurth, Mark J. ; Takada, Yoshikazu. / Identification of inhibitors against interaction between pro-inflammatory sPLA2-IIA protein and integrin αvβ3. In: Bioorganic and Medicinal Chemistry Letters. 2013 ; Vol. 23, No. 1. pp. 340-345.
@article{8e8149d7b56b4622bd26cb101b99dc5f,
title = "Identification of inhibitors against interaction between pro-inflammatory sPLA2-IIA protein and integrin αvβ3",
abstract = "Increased concentrations of secreted phospholipase A2 type IIA (sPLA2-IIA), have been found in the synovial fluid of patients with rheumatoid arthritis. It has been shown that sPLA2-IIA specifically binds to integrin αvβ3, and initiates a signaling pathway that leads to cell proliferation and inflammation. Therefore, the interaction between integrin and sPLA2-IIA could be a potential therapeutic target for the treatment of proliferation or inflammation-related diseases. Two one-bead-one-compound peptide libraries were constructed and screened, and seven target hits were identified. Herein we report the identification, synthesis, and biological testing of two pyrazolylthiazole-tethered peptide hits and their analogs. Biological assays showed that these compounds were able to suppress the sPLA2-IIA-integrin interaction and sPLA2-IIA-induced migration of monocytic cells and that the blockade of the sPLA2-IIA-integrin binding was specific to sPLA2-IIA and not to the integrin.",
keywords = "Inflammation, Inhibition of protein-protein interaction, Integrin, sPLA2-IIA",
author = "Long Ye and Tiffany Dickerson and Handeep Kaur and Takada, {Yoko K.} and Masaaki Fujita and Ruiwu Liu and Knapp, {John M.} and Kit Lam and Schore, {Neil E.} and Kurth, {Mark J.} and Yoshikazu Takada",
year = "2013",
month = "1",
day = "1",
doi = "10.1016/j.bmcl.2012.10.080",
language = "English (US)",
volume = "23",
pages = "340--345",
journal = "Bioorganic and Medicinal Chemistry Letters",
issn = "0960-894X",
publisher = "Elsevier Limited",
number = "1",

}

TY - JOUR

T1 - Identification of inhibitors against interaction between pro-inflammatory sPLA2-IIA protein and integrin αvβ3

AU - Ye, Long

AU - Dickerson, Tiffany

AU - Kaur, Handeep

AU - Takada, Yoko K.

AU - Fujita, Masaaki

AU - Liu, Ruiwu

AU - Knapp, John M.

AU - Lam, Kit

AU - Schore, Neil E.

AU - Kurth, Mark J.

AU - Takada, Yoshikazu

PY - 2013/1/1

Y1 - 2013/1/1

N2 - Increased concentrations of secreted phospholipase A2 type IIA (sPLA2-IIA), have been found in the synovial fluid of patients with rheumatoid arthritis. It has been shown that sPLA2-IIA specifically binds to integrin αvβ3, and initiates a signaling pathway that leads to cell proliferation and inflammation. Therefore, the interaction between integrin and sPLA2-IIA could be a potential therapeutic target for the treatment of proliferation or inflammation-related diseases. Two one-bead-one-compound peptide libraries were constructed and screened, and seven target hits were identified. Herein we report the identification, synthesis, and biological testing of two pyrazolylthiazole-tethered peptide hits and their analogs. Biological assays showed that these compounds were able to suppress the sPLA2-IIA-integrin interaction and sPLA2-IIA-induced migration of monocytic cells and that the blockade of the sPLA2-IIA-integrin binding was specific to sPLA2-IIA and not to the integrin.

AB - Increased concentrations of secreted phospholipase A2 type IIA (sPLA2-IIA), have been found in the synovial fluid of patients with rheumatoid arthritis. It has been shown that sPLA2-IIA specifically binds to integrin αvβ3, and initiates a signaling pathway that leads to cell proliferation and inflammation. Therefore, the interaction between integrin and sPLA2-IIA could be a potential therapeutic target for the treatment of proliferation or inflammation-related diseases. Two one-bead-one-compound peptide libraries were constructed and screened, and seven target hits were identified. Herein we report the identification, synthesis, and biological testing of two pyrazolylthiazole-tethered peptide hits and their analogs. Biological assays showed that these compounds were able to suppress the sPLA2-IIA-integrin interaction and sPLA2-IIA-induced migration of monocytic cells and that the blockade of the sPLA2-IIA-integrin binding was specific to sPLA2-IIA and not to the integrin.

KW - Inflammation

KW - Inhibition of protein-protein interaction

KW - Integrin

KW - sPLA2-IIA

UR - http://www.scopus.com/inward/record.url?scp=84870994262&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84870994262&partnerID=8YFLogxK

U2 - 10.1016/j.bmcl.2012.10.080

DO - 10.1016/j.bmcl.2012.10.080

M3 - Article

VL - 23

SP - 340

EP - 345

JO - Bioorganic and Medicinal Chemistry Letters

JF - Bioorganic and Medicinal Chemistry Letters

SN - 0960-894X

IS - 1

ER -